<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/pf.v22i4.2940</article-id><article-id custom-type="elpub" pub-id-type="custom">ppharm-2678</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT REPORT</subject></subj-group></article-categories><title-group><article-title>Клинический случай спорадической мутации гена TP63 с комбинированным иммунодефицитом и ранее не описанной генетической мутацией (HG3B)</article-title><trans-title-group xml:lang="en"><trans-title>Sporadic TP63 Gene Mutation with Combined Immunodeficiency and a Previously Unreported Genetic Mutation (HG3B): Case Report</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-5363-5747</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алданьязов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Aldanyazov</surname><given-names>Amanzhan S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алданьязов Аманжан Саматович, студент 5-го курса лечебного факультета </p><p>460000, Оренбург, Советская ул., д. 6, тел.: +7 (961) 917-67-94 </p></bio><bio xml:lang="en"><p>student </p><p>6, Sovetskaya Str., Orenburg, 460000 </p></bio><email xlink:type="simple">amanzhanaldanyazov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6306-7104</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попова</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Popova</surname><given-names>Larisa Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попова Лариса Юрьевна, д.м.н., профессор </p><p>Оренбург</p></bio><bio xml:lang="en"><p>MD, PhD, Professor </p><p>Orenburg </p></bio><email xlink:type="simple">docpopova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4792-6989</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Злодеева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zlodeeva</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Злодеева Елена Алексеевна, к.м.н.  </p><p>Оренбург</p></bio><bio xml:lang="en"><p>MD, PhD</p><p>Orenburg </p></bio><email xlink:type="simple">odpodkb@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6687-892X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алеманова</surname><given-names>Г. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Alemanova</surname><given-names>Galina D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алеманова Галина Дмитриевна, д.м.н.  </p><p>Оренбург</p></bio><bio xml:lang="en"><p>MD, PhD </p><p>Orenburg </p></bio><email xlink:type="simple">galina.alemanova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0441-1734</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Альбакасова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Albakasova</surname><given-names>Akmer A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Альбакасова Акмер Аманжуловна, к.м.н.  </p><p>Оренбург</p></bio><bio xml:lang="en"><p>MD, PhD </p><p>Orenburg </p></bio><email xlink:type="simple">albodkb@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Масагутова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Masagutova</surname><given-names>Alfiya M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Масагутова Альфия Митхатовна </p><p>Оренбург</p></bio><bio xml:lang="en"><p>MD </p><p>Orenburg </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-0707-6413</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дёндёши</surname><given-names>Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Dyondyoshi</surname><given-names>David</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дёндёши Давид, студент  </p><p>Оренбург</p></bio><bio xml:lang="en"><p>student </p><p>Orenburg </p></bio><email xlink:type="simple">ilovesnickers7@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-4868-0905</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макенова</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Makenova</surname><given-names>Alina K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макенова Алина Куандыковна, студентка </p><p>Оренбург</p></bio><bio xml:lang="en"><p>student </p><p>Orenburg </p></bio><email xlink:type="simple">makenovaaa854@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-5887-1687</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Объедкова</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Obyedkova</surname><given-names>Darya S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Объедкова Дарья Сергеевна, студентка </p><p>Оренбург</p></bio><bio xml:lang="en"><p>student </p><p>Orenburg </p></bio><email xlink:type="simple">dasha10obeydkova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-5083-0895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифоров</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforov</surname><given-names>Ilya N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифоров Илья Николаевич, студент </p><p>Оренбург</p></bio><bio xml:lang="en"><p>student </p><p>Orenburg </p></bio><email xlink:type="simple">Iliya255555@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Оренбургский государственный медицинский университет<country>Россия</country></aff><aff xml:lang="en">Orenburg State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Областная детская клиническая больница<country>Россия</country></aff><aff xml:lang="en">Oblast Children’s Clinical Hospital<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>10</month><year>2025</year></pub-date><volume>22</volume><issue>4</issue><fpage>523</fpage><lpage>529</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Алданьязов А.С., Попова Л.Ю., Злодеева Е.А., Алеманова Г.Д., Альбакасова А.А., Масагутова А.М., Дёндёши Д., Макенова А.К., Объедкова Д.С., Никифоров И.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Алданьязов А.С., Попова Л.Ю., Злодеева Е.А., Алеманова Г.Д., Альбакасова А.А., Масагутова А.М., Дёндёши Д., Макенова А.К., Объедкова Д.С., Никифоров И.Н.</copyright-holder><copyright-holder xml:lang="en">Aldanyazov A.S., Popova L.Y., Zlodeeva E.A., Alemanova G.D., Albakasova A.A., Masagutova A.M., Dyondyoshi D., Makenova A.K., Obyedkova D.S., Nikiforov I.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/2678">https://www.pedpharma.ru/jour/article/view/2678</self-uri><abstract><p>Обоснование. Представленный клинический случай демонстрирует редко описываемое в литературе сочетание спорадической мутации гена TP63 с ранее не описанной генетической мутацией HG3B, что привело к комбинированному иммунодефициту с множественными врожденными пороками развития. Уникальность случая определяется нетипичной комбинацией генетических нарушений и их клинических проявлений. Описание клинического случая. Пациент мужского пола, 5 мес, с распространенными эритематозно-сквамозными поражениями кожи, локализованными на волосистой части головы, лице и конечностях, с множественными врожденными пороками развития, включая расщелину мягкого и твердого неба, гипоспадию и аномалии почек. Выявлен комбинированный иммунодефицит с дефектом Т-клеточного звена, проявляющийся рецидивирующими инфекциями. На основании комплексного обследования установлен диагноз комбинированного иммунодефицита с дефектом Т-клеточного звена, ассоцииро ванного с мутацией гена TP63 и мутацией HG3B. Проведена комплексная терапия, включающая заместительную терапию иммуноглобулинами, антибактериальное лечение, наложение гастростомы. В результате лечения достигнута относительная стабилизация состояния пациента. Заключение. Описанный клинический случай расширяет представления о спектре клинических проявлений при мутациях гена TP63 и демонстрирует необходимость дальнейшего изучения роли новых генетических мутаций в патогенезе иммунодефицитных состояний. Случай подчеркивает важность мультидисциплинарного подхода к диагностике и лечению редких генетических заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>Background. The presented case report demonstrates a rarely described in the literature combination of a sporadic mutation of the TP63 gene with a previously unreported genetic mutation of HG3B, which led to a combined immunodeficiency with multiple congenital malformations. The uniqueness of the case is determined by an atypical combination of genetic disorders and their clinical manifestations. Case Report. A 5-month-old male patient with widespread erythematous-squamous skin lesions on the scalp, face, and extremities, as well as multiple congenital malformations, including cleft palate, hypospadias, and renal abnormalities. The patient was diagnosed with combined immunodeficiency with a T-cell defect, which manifested as recurrent infections. Based on a comprehensive examination, a diagnosis of combined immunodeficiency with a T-cell defect associated with a TP63 gene mutation and an HG3B mutation was made. A comprehensive therapy was carried out, including replacement therapy with immunoglobulins, antibacterial treatment, and the placement of a gastrostomy. As a result of the treatment, the patient’s condition was relatively stabilized. Conclusion. The described case report expands the understanding of the spectrum of clinical manifestations in TP63 gene mutations and demonstrates the need for further study of the role of new genetic mutations in the pathogenesis of immunodeficiency conditions. This case report highlights the importance of a multidisciplinary approach in the diagnosis and treatment of rare genetic diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>комбинированный иммунодефицит</kwd><kwd>мутация гена TP63</kwd><kwd>генетическая мутация HG3B</kwd><kwd>клинический случай</kwd><kwd>множественные врожденные пороки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>combined immunodeficiency</kwd><kwd>TP63 gene mutation</kwd><kwd>HG3B genetic mutation</kwd><kwd>case report</kwd><kwd>multiple congenital malformations</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Отсутствует.</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>Not specified.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sutton VR, van Bokhoven H. TP63-Related Disorders. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.</mixed-citation><mixed-citation xml:lang="en">Sutton VR, van Bokhoven H. TP63-Related Disorders. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Helenius K, Ojala L, Kainulainen L, et al. Overlap between EEC and AEC syndrome and immunodeficiency in a preterm infant with a TP63 variant. Eur J Med Genet. 2023;66(5):104735. doi: https://doi.org/10.1016/j.ejmg.2023.104735</mixed-citation><mixed-citation xml:lang="en">Helenius K, Ojala L, Kainulainen L, et al. Overlap between EEC and AEC syndrome and immunodeficiency in a preterm infant with a TP63 variant. Eur J Med Genet. 2023;66(5):104735. doi: https://doi.org/10.1016/j.ejmg.2023.104735</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Giampietro PF, Baker MW, Basehore MJ, et al. Novel mutation in TP63 associated with ectrodactyly ectodermal dysplasia and clefting syndrome and T cell lymphopenia. Am J Med Genet A. 2013;161A(6):1432–1435. doi: https://doi.org/10.1002/ajmg.a.35926</mixed-citation><mixed-citation xml:lang="en">Giampietro PF, Baker MW, Basehore MJ, et al. Novel mutation in TP63 associated with ectrodactyly ectodermal dysplasia and clefting syndrome and T cell lymphopenia. Am J Med Genet A. 2013;161A(6):1432–1435. doi: https://doi.org/10.1002/ajmg.a.35926</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–1507. doi: https://doi.org/10.1007/s10875-022-01295-4</mixed-citation><mixed-citation xml:lang="en">Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–1507. doi: https://doi.org/10.1007/s10875-022-01295-4</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lev A, Somech R, Somekh I. Newborn screening for severe combined immunodeficiency and inborn errors of immunity. Curr Opin Pediatr. 2023;35(6):692–702. doi: https://doi.org/10.1097/MOP.0000000000001106</mixed-citation><mixed-citation xml:lang="en">Lev A, Somech R, Somekh I. Newborn screening for severe combined immunodeficiency and inborn errors of immunity. Curr Opin Pediatr. 2023;35(6):692–702. doi: https://doi.org/10.1097/MOP.0000000000001106</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Amatuni GS, Currier RJ, Church JA, et al. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010–2017. Pediatrics. 2019;143(2):e20182300. doi: https://doi.org/10.1542/peds.2018-230300</mixed-citation><mixed-citation xml:lang="en">Amatuni GS, Currier RJ, Church JA, et al. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010–2017. Pediatrics. 2019;143(2):e20182300. doi: https://doi.org/10.1542/peds.2018-230300</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Giovannini S, Wang T, et al. p63: A crucial player in epithelial stemness regulation. Oncogene. 2023;42(46):3371–3384. doi: https://doi.org/10.1038/s41388-023-02669-0</mixed-citation><mixed-citation xml:lang="en">Li Y, Giovannini S, Wang T, et al. p63: A crucial player in epithelial stemness regulation. Oncogene. 2023;42(46):3371–3384. doi: https://doi.org/10.1038/s41388-023-02669-0</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van Bokhoven H, Brunner HG. Splitting p63. Am J Hum Genet. 2002;71(1):1–13. doi: https://doi.org/10.1086/341868</mixed-citation><mixed-citation xml:lang="en">van Bokhoven H, Brunner HG. Splitting p63. Am J Hum Genet. 2002;71(1):1–13. doi: https://doi.org/10.1086/341868</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues CHM, Pires DEV, Ascher DB. DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 2021;30(1):60–69. doi: https://doi.org/10.1002/pro.3942</mixed-citation><mixed-citation xml:lang="en">Rodrigues CHM, Pires DEV, Ascher DB. DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 2021;30(1):60–69. doi: https://doi.org/10.1002/pro.3942</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, deathinducing, and dominant-negative activities. Mol Cell. 1998;2(3): 305–316. doi: https://doi.org/10.1016/S1097-2765(00)80259-4</mixed-citation><mixed-citation xml:lang="en">Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, deathinducing, and dominant-negative activities. Mol Cell. 1998;2(3): 305–316. doi: https://doi.org/10.1016/S1097-2765(00)80259-4</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Melino G, Memmi EM, Pelicci PG, Bernassola F. Maintaining epithelial stemness with p63. Sci Signal. 2015;8(387):re9. doi: https://doi.org/10.1126/scisignal.aaa1248</mixed-citation><mixed-citation xml:lang="en">Melino G, Memmi EM, Pelicci PG, Bernassola F. Maintaining epithelial stemness with p63. Sci Signal. 2015;8(387):re9. doi: https://doi.org/10.1126/scisignal.aaa1248</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dotto J, Pelosi G, Rosai J. Expression of p63 in thymomas and normal thymus. Am J Clin Pathol. 2007;127(3):415–420. doi: https://doi.org/10.1309/4F3U-TR6S-3LCE-J3EA</mixed-citation><mixed-citation xml:lang="en">Dotto J, Pelosi G, Rosai J. Expression of p63 in thymomas and normal thymus. Am J Clin Pathol. 2007;127(3):415–420. doi: https://doi.org/10.1309/4F3U-TR6S-3LCE-J3EA</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang HX, Pan W, Zheng L, et al. Thymic Epithelial Cells Contribute to Thymopoiesis and T Cell Development. Front Immunol. 2019;10:3099. doi: https://doi.org/10.3389/fimmu.2019.3099</mixed-citation><mixed-citation xml:lang="en">Wang HX, Pan W, Zheng L, et al. Thymic Epithelial Cells Contribute to Thymopoiesis and T Cell Development. Front Immunol. 2019;10:3099. doi: https://doi.org/10.3389/fimmu.2019.3099</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Ruiz GU, Morales-Sanchez A, Bhandoola A. Transcriptional and epigenetic regulation in thymic epithelial cells. Immunol Rev. 2022;305(1):43–58. doi: https://doi.org/10.1111/imr.13034</mixed-citation><mixed-citation xml:lang="en">Martinez-Ruiz GU, Morales-Sanchez A, Bhandoola A. Transcriptional and epigenetic regulation in thymic epithelial cells. Immunol Rev. 2022;305(1):43–58. doi: https://doi.org/10.1111/imr.13034</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8(2):494–501.</mixed-citation><mixed-citation xml:lang="en">Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8(2):494–501.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Collins C, Sharpe E, Silber A, et al. Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment J Clin Immunol. 2021;41(5):881–895. doi: https://doi.org/10.1007/s10875-021-01064-5</mixed-citation><mixed-citation xml:lang="en">Collins C, Sharpe E, Silber A, et al. Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment J Clin Immunol. 2021;41(5):881–895. doi: https://doi.org/10.1007/s10875-021-01064-5</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Candi E, Rufini A, Terrinoni A, et al. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci U S A. 2007;104(29):11999–12004. doi: https://doi.org/10.1073/pnas.0704023104</mixed-citation><mixed-citation xml:lang="en">Candi E, Rufini A, Terrinoni A, et al. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci U S A. 2007;104(29):11999–12004. doi: https://doi.org/10.1073/pnas.0704023104</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Russo C, Osterburg C, Sirico A, et al. Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome. Proc Natl Acad Sci U S A. 2018;115(5):E906–E915. doi: https://doi.org/10.1073/pnas.1717966115</mixed-citation><mixed-citation xml:lang="en">Russo C, Osterburg C, Sirico A, et al. Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome. Proc Natl Acad Sci U S A. 2018;115(5):E906–E915. doi: https://doi.org/10.1073/pnas.1717966115</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Osterburg C, Dotsch V. Structural diversity of p63 and p73 isoforms. Cell Death Differ. 2022;29(5):921–937. doi: https://doi.org/10.1038/s41418-022-00987-0</mixed-citation><mixed-citation xml:lang="en">Osterburg C, Dotsch V. Structural diversity of p63 and p73 isoforms. Cell Death Differ. 2022;29(5):921–937. doi: https://doi.org/10.1038/s41418-022-00987-0</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ефимова Е.Ю., Мухина А.А., Балинова Н.В. и др. Нео натальный скрининг на первичные иммунодефицитные состояния как способ выявления синдромальных форм патологии новорожденных: клинический случай синдрома 22q11.2DS // Вопросы гематологии/ онкологии и иммунопатологии в педиатрии. — 2022. — Т. 21. — № 4. — С. 158–162. — doi: https://doi.org/10.24287/1726-1708-2022-21-4-158-162</mixed-citation><mixed-citation xml:lang="en">Efimova EYu, Mukhina AA, Balinova NV, et al. Newborn screening for primary immunodeficiencies as a way to detect syndromal disorders in neonates: a clinical case of 22q11.2DS syndrome. Pediatric Hematology/Oncology and Immunopathology. 2022;21(4):158–162. (In Russ). doi: https://doi.org/10.24287/1726-1708-2022-21-4-158-162</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Воронин С.В., Зинченко Р.А., Ефимова И.Ю. и др. Неонатальный скрининг, постнатальная диагностика и тактика доклинического лечения и профилактики первичных иммунодефицитов у детей // Педиатрия. Журнал им. Г.Н. Сперанского. — 2023. — Т. 102. — № 2. — С. 11–33. — doi: https://doi.org/10.24110/0031-403X-2023-102-2-11-33</mixed-citation><mixed-citation xml:lang="en">Voronin SV, Zinchenko RA, Efimova IYu, et al. Neonatal screening, postnatal diagnosis and tactics of preclinical treatment and prevention of primary immunodeficiencies in children. Guidelines by the experts from the National Association of Experts in Primary Immunodeficiencies (NAEPID) and the Association of Medical Genetics (AMG) of Russia. Pediatria. Journal n.a. G.N. Speransky. 2023;102(2):11–33. (In Russ). doi: https://doi.org/10.24110/0031-403X-2023-102-2-11-33</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abramson J, Adler J, Dunger J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493– 500. doi: https://doi.org/10.1038/s41586-024-xxxx</mixed-citation><mixed-citation xml:lang="en">Abramson J, Adler J, Dunger J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493– 500. doi: https://doi.org/10.1038/s41586-024-xxxx</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Goddard TD, Huang CC, Meng EC, et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 2018;27(1):14–25. doi: https://doi.org/10.1002/pro.3323</mixed-citation><mixed-citation xml:lang="en">Goddard TD, Huang CC, Meng EC, et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 2018;27(1):14–25. doi: https://doi.org/10.1002/pro.3323</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
